Awarded

The Provision of a Residential Substance Use Medically Managed Detoxification Service

Descriptions

The purpose of the residential medically managed detoxification service is to provide a safe, evidence based,effective detoxification and stabilisation programme to aid the recovery and reintegration of substance misusers with complex needs.Within Sefton Integrated Substance Misuse Treatment Service, the first-line detoxification offer is community detoxification within the adult treatment service. Where increased risk is indicated, residential in-patient detoxification may be the safest and most effective treatment plan. Medical input and supervision can be provided by a community GP overseeing the detoxification plan.However, medically managed inpatient detoxification is an important treatment option for service users who:— have not benefited from previous formal community-based and/or medically supervised inpatient detoxification;— need 24-hour specialist substance misuse medical and/or nursing care because of significant co-morbid physical or mental health problems;— require complex polydrug detoxification, for example concurrent detoxification from alcohol orbenzodiazepines;— are experiencing significant vulnerabilities or social problems that will limit the benefit of community-based detoxification;— have complex needs that require admission for medical stabilisation.The particular aims of the service are:— to provide a safe period of medically managed and monitored (by exception) withdrawal and detoxification, with 24-hour medical supervision;— to encourage, educate, motivate and enable realistic lifestyle changes;— to ensure that treatment gains are maintained by developing robust links with aftercare support available within the community, including mental health services;— to address the safeguarding and welfare needs of vulnerable adult service users or the children of substance misusing parents, ensuring that needs are identified and planned for prior to a person’s discharge from inpatient care;— to ensure that the principles of harm minimisation underpin the delivery of all interventions in order to reduce the harm caused by drugs and alcohol on individuals, thereby contributing to a reduction in drug and alcohol related deaths and the transmission of blood borne viruses.This procurement is being undertaken in accordance with section 7 of the Public Contracts Regulations 2015,also know as the ‘Light Touch’ regime under the EU Procurement Directives.

Timeline

Published Date :

26th Feb 2021 4 years ago

Deadline :

N/A

Tender Awarded :

1 Supplier

Awarded date :

2nd Feb 2021

Contract Start :

N/A

Contract End :

N/A

Tender Regions

CPV Codes

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Awarded

Assign to :

Tender Progress :

0%

Details

Notice Type :

Open opportunity

Tender Identifier :

IT-378-246-T: 2024 - 001

TenderBase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Region :

North Region

Attachments :

Buyer Information

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement Contact

Name :

Tina Smith

Designation :

Chief Executive Officer

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk

Possible Competitors

1 Possible Competitors